128 related articles for article (PubMed ID: 37890158)
1. Metabolic Syndrome Accelerates the Age-Related Increase of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Tanaka S; Tsujimae M; Masuda A; Inoue J; Inomata N; Uemura H; Kohashi S; Nagao K; Masuda S; Abe S; Gonda M; Yamakawa K; Ashina S; Nakano R; Tanaka T; Yamada Y; Sakai A; Kobayashi T; Shiomi H; Fujita K; Anami T; Fujita T; Watanabe A; Kodama Y
Pancreas; 2024 Jan; 53(1):e9-e15. PubMed ID: 37890158
[TBL] [Abstract][Full Text] [Related]
2. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm.
Kashiwagi K; Seino T; Fukuhara S; Minami K; Horibe M; Iwasaki E; Takaishi H; Itoh K; Sugino Y; Inoue N; Iwao Y; Kanai T
Pancreas; 2018 Oct; 47(9):1087-1092. PubMed ID: 30028443
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
5. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
6. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
7. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
8. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
[TBL] [Abstract][Full Text] [Related]
9. Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study.
Johansson K; Mustonen H; Seppänen H; Lehtimäki TE
BMC Gastroenterol; 2022 Aug; 22(1):394. PubMed ID: 35989322
[TBL] [Abstract][Full Text] [Related]
10. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
11. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
[TBL] [Abstract][Full Text] [Related]
13. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm.
Nakagawa T; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Yagi Y; Yamanaka K; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
Pancreas; 2017 Apr; 46(4):582-588. PubMed ID: 28099253
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological Factors Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Dual Center Case-Control Study.
Bülow R; Tjaden C; Ittermann T; Hinz U; Klaiber U; Weiss FU; Aghdassi A; Heckler M; Kromrey ML; Völzke H; Hosten N; Büchler MW; Lerch MM; Hackert T
Pancreas; 2022 Mar; 51(3):250-255. PubMed ID: 35584382
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasms of the pancreas: clinical surveillance and malignant progression, multifocality and implications of a field-defect.
Remotti HE; Winner M; Saif MW
JOP; 2012 Mar; 13(2):135-8. PubMed ID: 22406584
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Larghi A; Panic N; Capurso G; Leoncini E; Arzani D; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Bulajic M; Ricciardi W; Boccia S
Ann Oncol; 2013 Jul; 24(7):1907-1911. PubMed ID: 23676419
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas.
Mito K; Saito M; Morita K; Maetani I; Sata N; Mieno M; Fukushima N
Pancreatology; 2018 Jun; 18(4):407-412. PubMed ID: 29650332
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
[TBL] [Abstract][Full Text] [Related]
19. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
[TBL] [Abstract][Full Text] [Related]
20. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.
Pollini T; Wong P; Maker AV
Ann Surg Oncol; 2023 Mar; 30(3):1453-1462. PubMed ID: 36600097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
